COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
Stopped Regulatory authority approval for the initial study design could not be obtained
Conditions
- Stable Angina
- Unstable Angina
- STEMI
- NSTEMI
- Coronary Disease
Interventions
- DEVICE: COMBO-Stent
- DRUG: Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
- DEVICE: Any drug eluting stent oder bare metal sent
- DRUG: ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
Sponsor
IHF GmbH - Institut für Herzinfarktforschung
Collaborators